Back to Top Skip to main content

DTRA contributes to historic Ebola vaccine effort

Air Force Staff Sgt. Lee Nembhard, an aeromedical evacuation technician assigned to the 375th Aeromedical Evacuation Squadron from Scott Air Force Base, Illinois, straps a simulated Ebola patient to a litter during a Transport Isolation System training exercise at Joint Base Charleston, South Carolina. (U.S. Air Force photo by Senior Airman Megan Munoz) Air Force Staff Sgt. Lee Nembhard, an aeromedical evacuation technician assigned to the 375th Aeromedical Evacuation Squadron from Scott Air Force Base, Illinois, straps a simulated Ebola patient to a litter during a Transport Isolation System training exercise at Joint Base Charleston, South Carolina. (U.S. Air Force photo by Senior Airman Megan Munoz)

Recommended Content:

Immunization Healthcare | Immunizations | Global Emerging Infections Surveillance | Global Health Engagement | Global Health Engagement

FORT BELVOIR, Va. — The team of researchers and program managers at the Defense Threat Reduction Agency (DTRA) that has worked to counter the threat of the Ebola Virus Disease (EVD) welcomed the announcement of the U.S. Food and Drug Administration’s (FDA) approval of the vaccine, Ervebo ®, to the pharmaceutical company Merck & Co., Inc., December 19, 2019.

The approval of the vaccine represents the culmination of nearly two decades of efforts by a host of teams from across the public and private sectors such as DTRA and Merck, international partners in North America, Europe and Africa, and non-governmental and international organizations. The World Health Organization (WHO) describes EVD as a rare but severe hemorrhagic fever. EVD has killed thousands over the course of outbreaks, primarily in sub-Saharan Africa, since it first appeared in the 1970s.

DTRA, a Department of Defense combat support agency that identifies and combats biological threats as part of its mission to counter weapons of mass destruction (WMD), began its work on the vaccine in 2014 during an especially deadly outbreak in West Africa. The outbreak made clear the danger EVD posed to U.S. national security interests abroad, as well as to the U.S. domestic population in the event of a pandemic. To counter the threat, DTRA quickly initiated a strategy to get a vaccine approved. The combat support agency coordinated a series of investment efforts and partnerships to deliver a baseline platform for a viable vaccine candidate to mitigate the spread of the deadly disease.

“DTRA’s agile contracting, and well-placed contacts throughout government, academia, and industry allowed DTRA to form partnerships and guide development of this vaccine from the early stages of development, through crucial preclinical, and critical phase 1 clinical safety trials to the actual phase 2 clinical efficacy trial that demonstrated effectiveness of this vaccine during the outbreak,” said L. Revell Phillips Ph.D., a member of DTRA’s research and development team.

DTRA’s pioneering approach started with a contract to BioProtection Systems, a small biotech company. DTRA and BioProtection Systems partnered with Public Health Agency Canada, who began developing the vaccine in 2001, to accelerate its development. With these three teams working together, the vaccine progressed to a series of nonclinical and clinical studies conducted at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID) and Walter Reed Army Institute of Research (WRAIR) defense laboratories.

As the effort evolved, DTRA leveraged its USAMRIID partner’s research capacity, resulting in international partnering agreements with the WHO. DTRA also coordinated with teams across the U.S. government as development of the vaccine progressed. The efforts of this research and development consortium produced viable data that would be transitioned to next-level partners.

“We exercised our ability to develop partnerships for a relevant need, which was critical in transitioning medical countermeasures to our advanced developers at the speed of relevancy,” said Army Maj. Jeffrey Froude, DTRA’s program manager for the EVD Vaccine.

Froude explained that DTRA bolstered its research and development investments through two key U.S. governmental partners. First, DTRA worked closely with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, for advanced trials and manufacturing activities. Second, DTRA teamed with the DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for the task of immunoassay development. For that development effort, JPEO-CBRND’s, office of the Joint Program Manager for CBRN Medical took the lead.

Following several years of coordinated research and development efforts by the coalition of partners, the promising vaccine candidate transitioned to next-level partners BARDA and Merck for more advanced human clinical trials and product manufacturing of the EVD vaccine.

“This vaccine’s rapid progress is a testament to the power of partnerships among government agencies and with the private sector,” said BARDA director Rick Bright.

Next-level partner BARDA and Merck, served as the transition point to conduct more advanced human clinical trials and product manufacturing on the Ebola vaccine with the Joint Program Executive office (JPEO) providing a testing capability that allowed Merck to test human and non-human primate samples. The Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical (JPM-CBRN), Army Col. Ryan Eckmeier, stated that this “interagency partnership from the beginning was critical to advancing this vaccine product.”

Merck’s expertise with licensing and manufacturing was instrumental in advancing the vaccine. The pharmaceutical giant partnered with the WHO, United Nations International Children's Emergency Fund, and Gavi Vaccine Alliance, among others, to strategize on how to best implement future public health preparedness and response efforts against EVD.

“We share in this achievement, and thank you all personally for your amazing support over the last five years,” said Beth-Ann G. Coller, executive director of Merck’s vaccine team in a note to the DTRA team. “This has truly been a journey and one that we are proud to have shared with our colleagues in DoD. Without the early and continued support of DTRA we would not be here today.”

DTRA continues to leverage its successful partnerships as the agency works to develop future countermeasures. DTRA and BARDA have active partnering agreements to develop vaccine and therapeutic medical countermeasures to address a diverse range of viral and bacterial infectious disease threats. Efforts will use a similar model to the one that supported development and approval of the EVD vaccine.

“As DTRA moves forward to new challenges, we will leverage continued utilization of the Ebola vaccine model, using a diverse range of ways that we can work with our academic, international, interagency and industrial partners through grants, contracts and other transaction authorities,” said Froude. “We have a proven paradigm on how to efficiently advance medical countermeasures working with our U.S. government partners in these endeavors.”

Disclaimer: Re-published content may be edited for length and clarity. Read original post.

You also may be interested in...

Field emergency room drills strengthen bonds of U.S. Navy, Swedish medics

Article
4/24/2019
Navy Cmdr. Mark Lambert (center) and Navy Hospital Corpsman 2nd Class Amos Bogs (right), work with Capt. Peter Landell (left), Swedish Armed Forces, during a multinational medical drill, Cincu Military Base, Romania, during exercise Vigorous Warrior 19. (U.S. Air Force photo by 1st Lt. Andrew Layton)

Vigorous Warrior is a biannual readiness event organized by the NATO Military Medicine Centre of Excellence

Recommended Content:

Global Health Engagement

Medical logistics Airmen enable lifesaving skills at NATO exercise

Article
4/18/2019
Civilian first responders from Romania participate along with Airmen from the 86th Medical Group, Ramstein Air Base, Germany, in a multinational medical exercise drill during Vigorous Warrior 19, Cincu Military Base, Romania. Vigorous Warrior 19 is NATO’s largest military medical exercise, uniting more than 2,500 participants from 39 countries to exercise experimental doctrinal concepts and test their medical assets together in a dynamic, multinational environment. (U.S. Air Force photo by 1st Lt. Andrew Layton)

Uniting upwards of 2,500 providers from 39 countries, the exercise is the largest medical readiness event in NATO

Recommended Content:

Health Readiness | Medical Logistics | Global Health Engagement

Resolution of Payments to State Vaccine Programs

Congressional Testimony
4/17/2019

S. 3159, SAC Report for FY 2019, 115-290, Pg. 207

Recommended Content:

Immunization Healthcare

How The U.S. Military Is Contributing To The Fight Against Cholera In Mozambique

Video
4/16/2019
Air Force Capt. Talon Miner, a flight surgeon assigned to the 435th Contingency Response Group, Ramstein Air Base, Germany, supporting Combined Joint Task Force-Horn of Africa, discusses the role that the U.S. Department of Defense is undertaking to combat the spread of Cholera in Mozambique.

Air Force Capt. Talon Miner, a flight surgeon assigned to the 435th Contingency Response Group, Ramstein Air Base, Germany, supporting Combined Joint Task Force-Horn of Africa

Recommended Content:

Global Health Engagement | Global Health Security Agenda | Building Partner Capacity and Interoperability | Humanitarian Assistance and Disaster Relief

Africa Malaria Task Force Key Leader Event continues fight against malaria

Article
4/12/2019
Brig. Gen. Dowlo Yao, Chief of Health Services, Cote D’Ivoire Armed Forces and Chairman of Africa Malaria Task Force, asks a question during the AMTF Key Leader Event. (DoD photo).

The primary goal of AMTF has been to assist African partner militaries do develop relationships with their national malaria control programs

Recommended Content:

Global Health Engagement | Global Health Security Agenda

Military nursing exchange brings together 23 partner nations

Article
4/12/2019
Medical professionals from around Europe and Africa receive small-group training at Ramstein Air Base, Germany. The 2019 European African Military Nursing Exchange is the 6th iteration of its kind, with extensive planning and coordination to connect partner nations in a collaborative environment that promotes hands-on training scenarios. (U.S. Air Force photo by Tech. Sgt. Jessica Hines)

United States, European and African military nurses focused on each nation’s unique cultures, communication patterns and capacity for interoperability

Recommended Content:

Global Health Engagement

Measles vaccine protects against potentially serious illness

Article
4/4/2019
A Salvadoran nurse vaccinates a baby during a Task Force Northstar mission in El Salvador to provide medical care and other humanitarian and civic assistance. The mission involved U.S. military personnel working alongside their Brazilian, Canadian, Chilean, and Salvadoran counterparts. (U.S. Army Photo by Sgt. Kim Browne)

387 cases to date among civilian population

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Recommendations | Children's Health

Pacific Partnership 2019 introduces helicopter en route medical care

Article
3/29/2019
A Philippine Fire Department rescue worker lifts a simulated earthquake victim onto a Philippine Air Force rescue helicopter during the Pacific Partnership 2019 exercise in Tacloban, Philippines. The goal of the Pacific Partnership is to improve interoperability of the region's military forces, governments, and humanitarian organizations during disaster relief operations, while providing humanitarian, medical, dental, and engineering assistance to nations of the Pacific all while strengthening relationships and security ties between the partner nations (U.S. Air Force photo by Tech. Sgt. Andrew Jackson)

The exercise is an important part of disaster risk reduction

Recommended Content:

Health Readiness | Global Health Engagement | Building Partner Capacity and Interoperability | Global Health Security Agenda | Global Health Engagement

Pacific Partnership 2019 participates in community health engagement in Tacloban

Article
3/21/2019
Navy Lt. Sharon Hoff (right) listens to a patient’s heartbeat as Philippine Army Capt. Glorife Saura from the Armed Forces of the Philippines Medical Corps records patient vital signs. Pacific Partnership participants and Tacloban City medical professionals worked together to provide medical and veterinary services throughout the day at Tigbao Diit Elementary School. (U.S. Navy photo by Mass Communication Specialist 1st Class Nathan Carpenter)

Pacific Partnership 2019 exchanges create lasting bonds of friendship and trust

Recommended Content:

Health Readiness | Global Health Engagement | Global Health Security Agenda

Global Health Engagement in action: Trinidad and Tobago

Article
2/22/2019
Navy Lt. David Cruz, Southern Partnership Station 2018’s Fleet Health Engagement Team officer-in-charge, speaks with a Trinidad and Tobago military professional as part of functional exercise Red Fish aboard a TTO coast guard vessel during Southern Partnership Station 2018. (U.S. Navy photo by Mass Communication Specialist 3rd Class Katie Cox)

The U.S. Navy’s Global Health Engagement missions are inherently collaborative

Recommended Content:

Global Health Engagement | Global Health Security Agenda

Medical helps prevent the flu amongst service members through teamwork

Article
2/15/2019
Members of DLA Troop Support Medical supply chain and DLA Distribution pose for a photo at an after action review for the Department of Defense’s Influenza Vaccination Program at Fort Detrick, Maryland Feb. 5, 2019. The Medical supply chain made approximately 3.4 million doses of the influenza vaccine available at military treatment facilities and U.S. Navy Fleet clinics around the world in support of the DOD’s Influenza Vaccination Program. (DoD photo by Alexander Quiñones)

The Medical supply chain made approximately 3.4 million doses of the influenza vaccine available

Recommended Content:

Immunization Healthcare | Immunizations | Combat Support

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019

Report
2/8/2019

The 2019 child and adolescent immunization schedule summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP), including several changes from the 2018 immunization schedule.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Hospital ship USNS Comfort returns home after completing mission

Article
12/20/2018
Family and friends of crew members aboard Military Sealift Command’s hospital ship USNS Comfort wait as the ship pulls into Naval Station Norfolk, Dec. 18. Comfort returned to Virginia after completing its 11-week medical support mission to South and Central America, part of U.S. Southern Command’s Operation Enduring Promise initiative. (U.S. Navy photograph by Brian Suriani)

This mission marked the sixth time the hospital ship has provided medical assistance in the region

Recommended Content:

Health Readiness | Military Hospitals and Clinics | Global Health Engagement | Global Health Security Agenda

Leaders take world view to enhance health readiness

Article
12/19/2018
Army Maj. Elizabeth Polfer (left), an orthopedic surgeon at William Beaumont Army Medical Center in Texas, performs hand surgery with her Honduran counterpart in Tegucigalpa, Honduras, during a Regional Health Command-Central Global Health Engagement Medical Readiness Training Exercise. (U.S. Army photo by Maria Pinel)

Global engagements include missions in South, Central America

Recommended Content:

Global Health Engagement | Global Health Engagement

Vaccination is the best defense against the flu

Article
12/10/2018
Vaccination is the primary method for preventing influenza and its complications and getting an annual influenza vaccine is the best way to protect yourself and your family from the flu. (U.S. Army photo by Staff Sgt. Erica Knight)

Vaccination is needed every year because the Influenza viruses change

Recommended Content:

Health Readiness | Immunization Healthcare | Immunizations
<< < 1 2 3 4 5  ... > >> 
Showing results 61 - 75 Page 5 of 12

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.